New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Monopar Therapeutics Inc.
MNPR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

63M

Biotechnology

Next Earning date - 14 Nov 2024

63M

Biotechnology

Next Earning date - 14 Nov 2024

17.83USD
Shape0.90 ( 5.32%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

92%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated October 29, 2024
1W 285.10 % 1M 164.54 % 3M 409.43 % 1Y 782.67 %

Key Metrics

Shape
  • Market Cap

    62.77M


  • Shares Outstanding

    3.52M


  • Share in Float

    1.76M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    17.83


  • Average Volume

    1.19M


  • Beta

    1.261


  • Range

    1.37-38.5


  • Industry

    Biotechnology


  • Website

    https://www.monopartx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

11.00x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-2.3

EPS

How MNPR compares to sector?

P/E Ratio

Relative Strength

Shape

MNPR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$4.90

Shape-901%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-10-11

Now: Buy

Roth Capital

initialise

Previous: Not converted

2021-01-28

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.95
vs -1.00

Q4.22

arrow
arrow

N/A

-1.10
vs -1.05

Q1.23

arrow
arrow

N/A

-0.95
vs -0.95

Q2.23

arrow
arrow

N/A

-0.80
vs -1.10

Q3.23

arrow
arrow

N/A

-0.70
vs -0.95

Q4.23

arrow
arrow

N/A

-0.60
vs -1.10

Q1.24

arrow
arrow

N/A

-0.50
vs -0.95

Q2.24

arrow
arrow

N/A

-0.50
vs -0.80

Q3.24

arrow
arrow

N/A

-1.52
vs -0.70

Q4.24

arrow
arrow

N/A

-1.52
vs -0.60

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-19%

-0.19
vs -0.19

Q4.22

arrow
arrow

-29%

-0.29
vs -0.19

Q1.23

arrow
arrow

-26%

-0.26
vs -0.29

Q2.23

arrow
arrow

-28%

-0.28
vs -0.26

Q3.23

arrow
arrow

-30%

-0.30
vs -0.28

Q4.23

arrow
arrow

-32%

-0.32
vs -0.30

Q1.24

arrow
arrow

-22%

-0.22
vs -0.32

Q2.24

arrow
arrow

-28%

-0.28
vs -0.22

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

8

8
vs 10

-20%

Q4.22

arrow
arrow

10

10
vs 8

25%

Q1.23

arrow
arrow

11

11
vs 10

10%

Q2.23

arrow
arrow

8

8
vs 11

-27%

Q3.23

arrow
arrow

14

14
vs 8

75%

Q4.23

arrow
arrow

14

14
vs 14

NA

Q1.24

arrow
arrow

15

15
vs 14

7%

Q2.24

arrow
arrow

12

12
vs 15

-20%

Earnings Growth

Latest News